In other words, these findings support that the PI3K pathway plays a critical role in CRC pathogenesis and progression, providing new biomarkers for individualized treatment and prognostic evaluation and offering new directions for future therapeutic research and clinical practice. The gene discussed is PIK3CA; the disease is colorectal carcinoma.